BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2010
View Archived Issues
Recombinant polypeptide can extend half-life of proteins and peptides
Read More
Penwest initiates phase IIa trial of A-0001 in A3243G mitochondrial DNA point mutation
Read More
Detection of label-free biomarkers in whole blood samples reported
Read More
HSV-2 suppression with acyclovir does not reduce risk for HIV-1 transmission
Read More
Combined targeting of beta/gamma-secretase shows promise as new AD therapy
Read More
New therapeutic target found in NS4B protein of hepatitis C virus
Read More
Ablynx selected anti-CXCR4 Nanobody ALX-0651 for preclinical development
Read More
FDA approves SPA for phase III trial of HyperAcute immunotherapy in pancreatic cancer
Read More
Excelimmune receives Series B funding for development of Staphguard
Read More
Anacor regains worldwide rights to AN-2690 from Merck
Read More
Circassia reports phase II results with ragweed allergy T-cell vaccine
Read More
Synta reports STA-9090 results showing potent in vitro and in vivo activity in AML
Read More
FDA extends Horizant PDUFA date
Read More
Cerus reports outcome of phase I trial of Intercept red blood cells
Read More
PolyMedix reports milestones scheduled for 2010
Read More
Tyrogenex presents protein kinase inhibitors for cancer therapy
Read More
Theracos identifies novel sodium/glucose cotransporter inhibitors
Read More
New MR antagonists discovered at Bayer Schering Pharma
Read More
S1P1 receptor agonists discovered by GlaxoSmithKline
Read More
Janus kinase inhibitors identified by Merck & Co.
Read More
Genta initiates phase II tesetaxel trial in patients with advanced melanoma
Read More
YM BioSciences presents CYT-387 and CYT-997 data
Read More
Euthymics Bioscience signs letter of intent for acquisition of DOV
Read More
KineMed broadens collaboration with Bristol-Myers Squibb
Read More
Proteonomix forms wholly owned subsidiary PRTMI for stem cell research
Read More